Historique
Rapport
The global state of harm reduction 2024
Auteur(s) :
HRI (Harm Reduction International)
Année
2024
Page(s) :
213 p.
Langue(s) :
Anglais
Éditeur(s) :
London : HRI (Harm Reduction International)
, 9th edition
ISBN :
978-1-915255-17-4
Refs biblio. :
dissém.
Domaine :
Autres substances / Other substances ; Drogues illicites / Illicit drugs
Thésaurus géographique
INTERNATIONAL
;
EUROPE
;
ASIE
;
CARAIBES
;
AMERIQUE
;
OCEANIE
;
AFRIQUE
Thésaurus mots-clés
VIH
;
HEPATITE
;
PRISON
;
REDUCTION DES RISQUES ET DES DOMMAGES
;
POLITIQUE
;
INJECTION
;
ECHANGE DE SERINGUES
;
SUBSTITUTION
;
SURDOSE
;
PRODUIT ILLICITE
;
EFFICACITE
;
ACCES AUX SOINS
;
EPIDEMIOLOGIE
;
GEOGRAPHIE
;
TRAITEMENT DE MAINTENANCE
;
FENTANYL
;
MORTALITE
;
SALLE DE CONSOMMATION A MOINDRE RISQUE
;
NALOXONE
;
MILIEU FESTIF
;
FINANCEMENT
;
EVOLUTION
Résumé :
The Global State of Harm Reduction is the only report that provides an independent analysis of harm reduction in the world. Now in its the ninth edition, the Global State of Harm Reduction 2024 is the most comprehensive global mapping of harm reduction responses to drug use, HIV and viral hepatitis.
The Global State of Harm Reduction has always been produced through a collaborative effort between community and civil society representatives and researchers. The report includes nine regional chapters authored by experts from each region. This year’s report differs slightly from previous editions as we emphasise key regional issues and populations that continue to be
neglected by harm reduction services.
Each regional chapter presents data on the availability of harm reduction services and addresses two key issues that require special attention. The report also includes three new thematic chapters focused on harm reduction for Indigenous people, people in prison and youth. We also continue to include data to map the implementation of viral hepatitis services for people who use drugs. [Editor's abstract]
Top trends:
93 countries now provide at least one needle and syringe programme (NSP), compared to 92 in 2022.
Opioid agonist therapy (OAT) programmes are now in 94 countries, compared to 88 in 2022 - although coverage remains varied and limited.
The number of countries with drug consumption rooms (DCRs) or overdose preventions centres remains very small, but it has increased from 16 to 18 since 2022. The two new countries on this list are Colombia and Sierra Leone.
Take-home naloxone programmes are now available in 34 countries, a slight decrease from 35 in 2022.
The Global State of Harm Reduction has always been produced through a collaborative effort between community and civil society representatives and researchers. The report includes nine regional chapters authored by experts from each region. This year’s report differs slightly from previous editions as we emphasise key regional issues and populations that continue to be
neglected by harm reduction services.
Each regional chapter presents data on the availability of harm reduction services and addresses two key issues that require special attention. The report also includes three new thematic chapters focused on harm reduction for Indigenous people, people in prison and youth. We also continue to include data to map the implementation of viral hepatitis services for people who use drugs. [Editor's abstract]
Top trends:
93 countries now provide at least one needle and syringe programme (NSP), compared to 92 in 2022.
Opioid agonist therapy (OAT) programmes are now in 94 countries, compared to 88 in 2022 - although coverage remains varied and limited.
The number of countries with drug consumption rooms (DCRs) or overdose preventions centres remains very small, but it has increased from 16 to 18 since 2022. The two new countries on this list are Colombia and Sierra Leone.
Take-home naloxone programmes are now available in 34 countries, a slight decrease from 35 in 2022.
Affiliation :
UK
Titre précédent :